SLC25A5P4

Across TCGA pan-cancer cohorts, SLC25A5P4 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated SLC25A5P4 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher SLC25A5P4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SLC25A5P4 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

THCA, READ, and SKCM are the cancer types where SLC25A5P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	IV	0.095	0.966	<.001	54	view →
READ	OS	Tertile	IV	0.375	0.765	.014	33	view →
SKCM	DFS	Tertile	All	0.489	0.633	.007	27	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
BLCA	DFS	Tertile	IV	0.077	0.476	<.001	18	view →
STAD	OS	Quartile	II,III,IV	0.540	0.741	.033	13	view →
OV	DFS	Tertile	All	0.123	0.171	.043	6	view →
LUAD	DFS	Tertile	All	0.766	0.326	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

SLC25A5P4–THCA (OS)

Open the THCA breakdown →